Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Roche launches immunosuppressive therapy monitoring tests

Roche launches immunosuppressive therapy monitoring tests

23rd July 2013

Roche has announced the launch of two highly sensitive drug monitoring tests for assessing transplant patients receiving immunosuppressive therapy.

The new Elecsys Tacrolimus and Cyclosporine tests provide healthcare professionals with an accurate and reliable means of measuring levels of the common immunosuppressants tacrolimus and cyclosporine.

Made for use on Roche's cobas modular analysers, they support enhanced workflow and efficiency in medical laboratories and can play a key role in maintaining the long-term wellbeing of transplant recipients.

Immunosuppressants must be taken continuously by transplant patients to prevent tissue rejection and can fail to be effective if the dosage is too low, while an excessive dose will cause severe side effects.

Roland Diggelmann, head of Roche Diagnostics, said: "The launch of the new products marks another milestone in the expansion for Roche's test portfolio for transplantation. These highly sensitive tests provide healthcare professionals precise and consistent test results for effective treatment regime."

This follows on from the company's recent introduction of Elecsys ProGRP, a test that distinguishes between the two main types of lung cancer.ADNFCR-8000103-ID-801615885-ADNFCR

We currently have 9 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.